| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Puma Biotechnology, Inc.'s insiders have reduced their positions by a net 44,058 shares worth roughly $364K.
PBYI sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 7.26M | $64.70M | - | |
| CFO | 240.0K | $2.14M | - | |
| Other | 205.3K | $1.83M | - | |
| Dir | 54.0K | $481.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 2, 2019 | Bryce Richard Paul | See Remarks | Sell | 88 | $35.78 | $3,148.65 | -0.2% | |
| Apr 2, 2019 | Auerbach Alan H62 | President And CEO | Sell | 491 | $35.79 | $17,573.09 | - | |
| Mar 4, 2019 | Bryce Richard Paul | See Remarks | Sell | 88 | $38.66 | $3,402.08 | -0.2% | |
| Mar 4, 2019 | Auerbach Alan H62 | President And CEO | Sell | 496 | $38.62 | $19,155.52 | - | |
| Feb 4, 2019 | Eyler Charles R | See Remarks | Sell | 87 | $27.64 | $2,404.71 | -0.3% | |
| Feb 4, 2019 | Bryce Richard Paul | See Remarks | Sell | 89 | $27.77 | $2,471.53 | -0.3% | |
| Feb 4, 2019 | Auerbach Alan H62 | President And CEO | Sell | 345 | $27.80 | $9,591.00 | - | |
| Jan 22, 2019 | Lo Steven | Chief Commercial Officer | Sell | 2,114 | $24.91 | $52,663.55 | -9.0% | |
| Jan 22, 2019 | Bryce Richard Paul | See Remarks | Sell | 1,959 | $24.72 | $48,426.48 | -6.3% | |
| Jan 22, 2019 | Auerbach Alan H62 | President And CEO | Sell | 8,825 | $24.74 | $218,334.03 | -0.2% |